UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

Annals of oncology, 2013-02, Vol.24 (2), p.355-361

2013

Volltextzugriff (PDF)

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Journal of clinical oncology, 2001-07, Vol.19 (13), p.3210-3218

2001

Volltextzugriff (PDF)

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Journal of clinical oncology, 2001-06, Vol.19 (11), p.2875-2882

2001

Volltextzugriff (PDF)

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

Journal of clinical oncology, 1998-07, Vol.16 (7), p.2459-2465

1998

Volltextzugriff (PDF)

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

The New England journal of medicine, 1999-01, Vol.340 (4), p.265-271

1999

Volltextzugriff (PDF)

Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study

Annals of oncology, 2005-07, Vol.16 (7), p.1076-1080

2005

Volltextzugriff (PDF)

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17

Annals of oncology, 2008-05, Vol.19 (5), p.877-882

2008

Volltextzugriff (PDF)

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Breast cancer research and treatment, 2016-08, Vol.158 (3), p.485-495

2016

Volltextzugriff (PDF)

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

Journal of clinical oncology, 1997-04, Vol.15 (4), p.1395-1400

1997

Volltextzugriff (PDF)

Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non–Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy

Journal of clinical oncology, 2001-01, Vol.19 (2), p.448-457

2001

Volltextzugriff (PDF)

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

Journal of clinical oncology, 1991-09, Vol.9 (9), p.1618-1626

1991

Volltextzugriff (PDF)

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]‐sestamibi scintimammography

Cancer, 1999-06, Vol.85 (11), p.2410-2423

1999

Volltextzugriff (PDF)

Samarium-153-EDTMP in Bone Metastases of Hormone Refractory Prostate Carcinoma: A Phase I/II Trial

The Journal of nuclear medicine (1978), 1993-11, Vol.34 (11), p.1839

1993

Volltextzugriff (PDF)

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer

Lung cancer (Amsterdam, Netherlands), 2002-09, Vol.37 (3), p.303-309

2002

Volltextzugriff (PDF)

Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2300-2308

1999

Volltextzugriff (PDF)

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

The pharmacogenomics journal, 2014-06, Vol.14 (3), p.241-247

2014

Volltextzugriff (PDF)

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

Journal of clinical oncology, 1993-05, Vol.11 (5), p.873-878

1993

Volltextzugriff (PDF)

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

Journal of clinical oncology, 1998-09, Vol.16 (9), p.3078-3081

1998

Volltextzugriff (PDF)

Infusional Paclitaxel and Weekly Vinorelbine Chemotherapy With Concurrent Filgrastim for Metastatic Breast Cancer: High Complete Response Rate in a Phase I-II Study of Doxorubicin-Treated Patients

Journal of clinical oncology, 1999-05, Vol.17 (5), p.1407-1412

1999

Volltextzugriff (PDF)

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

Journal of clinical oncology, 1990-09, Vol.8 (9), p.1563-1574

1990

Volltextzugriff (PDF)

Effect of delay in radiation in the combined modality treatment of breast cancer

International journal of radiation oncology, biology, physics, 1993-04, Vol.26 (1), p.23-35

1993

Volltextzugriff (PDF)

Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial

The Journal of thoracic and cardiovascular surgery, 1993-01, Vol.105 (1), p.97-104; discussion 104-6

1993

Volltextzugriff (PDF)

Combined modality therapy of lung cancer

Clinical cancer research, 1997-12, Vol.3 (12), p.2638

Livingston, R B

1997

Volltextzugriff (PDF)

Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience

Chest, 1991-06, Vol.99 (6), p.1425-1432

1991

Volltextzugriff (PDF)

Psychological sub-types among persons with HIV infection: An empirical study

AIDS care, 2001-04, Vol.13 (2), p.157-162

2001

Volltextzugriff (PDF)

1 – 25 von 1.309

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.123)
Mit Volltextzugriff
(1.077)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(738)
Life Sciences & Biomedicine
(552)
Humans
(512)
Female
(311)
Biological And Medical Sciences
(255)
Male
(234)
Adult
(221)
Middle Aged
(209)
Medical Sciences
(208)
Oncology
(184)
Physical Sciences
(182)
Aged
(171)
Animals
(117)
Physics
(90)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(83)
Pharmacology. Drug Treatments
(83)
Lung Neoplasms - Drug Therapy
(77)
Chemotherapy
(71)
Antineoplastic Agents
(68)
Breast Neoplasms - Drug Therapy
(64)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole

Randomized Phase III Trial of Paclitaxel Plus Carboplatin Versus Vinorelbine Plus Cisplatin in the Treatment of Patients With Advanced Non–Small-Cell Lung Cancer: A Southwest Oncology Group Trial

Clinical Evaluation of Once-Weekly Dosing of Epoetin Alfa in Chemotherapy Patients: Improvements in Hemoglobin and Quality of Life Are Similar to Three-Times-Weekly Dosing

Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer: a Southwest Oncology Group study

Twice-Daily Compared with Once-Daily Thoracic Radiotherapy in Limited Small-Cell Lung Cancer Treated Concurrently with Cisplatin and Etoposide

Advanced bronchioloalveolar carcinoma: a phase II trial of paclitaxel by 96-hour infusion (SWOG 9714): a Southwest Oncology Group study

Intent-to-treat analysis of the placebo-controlled trial of letrozole for extended adjuvant therapy in early breast cancer: NCIC CTG MA.17

SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer

Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer

Lack of Prognostic Significance of p53 and K-ras Mutations in Primary Resected Non–Small-Cell Lung Cancer on E4592: A Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]‐sestamibi scintimammography

Samarium-153-EDTMP in Bone Metastases of Hormone Refractory Prostate Carcinoma: A Phase I/II Trial

The influence of gender on survival and tumor recurrence following adjuvant therapy of completely resected stages II and IIIa non-small cell lung cancer

Randomized Study of CODE Versus Alternating CAV/EP for Extensive-Stage Small-Cell Lung Cancer: An Intergroup Study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group

Germline genetic variants in ABCB1, ABCC1 and ALDH1A1, and risk of hematological and gastrointestinal toxicities in a SWOG Phase III trial S0221 for breast cancer

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group

Southwest Oncology Group phase II trial of concurrent carboplatin, etoposide, and radiation for poor-risk stage III non-small-cell lung cancer

Infusional Paclitaxel and Weekly Vinorelbine Chemotherapy With Concurrent Filgrastim for Metastatic Breast Cancer: High Complete Response Rate in a Phase I-II Study of Doxorubicin-Treated Patients

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

Effect of delay in radiation in the combined modality treatment of breast cancer

Surgical resection of stage IIIA and stage IIIB non-small-cell lung cancer after concurrent induction chemoradiotherapy. A Southwest Oncology Group trial

Combined modality therapy of lung cancer

Long-term survival and toxicity in small cell lung cancer. Expanded Southwest Oncology Group experience

Psychological sub-types among persons with HIV infection: An empirical study

Suchergebnisse filtern